Description

Dr. Williams, also a research fellow at Monash University, is co-leading a clinical trial at St Vincent’s hospital Melbourne into psilocybin-assisted psychotherapy to treat anxiety and depression in people who are terminally ill.

The trial, which will run until 2023, involves 40 people with terminal conditions such as chronic obstructive pulmonary disease and motor neurone disease, who are receiving either one or two 25-milligram doses of psilocybin in conjunction with therapy.

 Psychedelics … through whatever mechanisms, seem to represent a significant improvement over the standard therapies

It follows successful US studies of the drug in patients with anxiety and depression associated with life-threatening cancer. At follow-up four-and-a-half years later, participants “overwhelmingly attributed positive life changes to the psilocybin-assisted therapy experience and rated it among the most personally meaningful and spiritually significant experiences of their lives

 

Containes

• Vit E. pachanoi
• Mescaline (25 or more mg per 100 grams of fresh cactus)
• Dimethoxyphenethtlamine Methoxytyramine
• Hydroxy,
• Anhalonidine, 
• Hordenine
• Tyramine.

 

One of the best Mood enhancers.

A natural antibiotic

Contain mescaline and

Dopamine

Helps with PTSD

Mood disorders

Cancer

Acidity

Depression

Anxiety

Stress